This abnormal hypersensitivity, called explosive synchronisation (ES), can be seen in other network phenomena across nature, according to the study published in the journal Scientific Reports.
Researchers from the University of Michigan in the US and Pohang University of Science and Technology in South Korea report evidence of ES in the brains of people with fibromyalgia, a condition characterised by widespread, chronic pain.
"For the first time, this research shows that the hypersensitivity experienced by chronic pain patients may result from hypersensitive brain networks," said Richard Harris, from the University of Michigan.
In ES, a small stimulus can lead to a dramatic synchronised reaction in the network, as can happen with a power grid failure (that rapidly turns things off) or a seizure (that rapidly turns things on).
This phenomenon was, until recently, studied in physics rather than medicine. According to the researchers, it's a promising avenue to explore in the continued quest to determine how a person develops fibromyalgia.
"As opposed to the normal process of gradually linking up different centers in the brain after a stimulus, chronic pain patients have conditions that predispose them to linking up in an abrupt, explosive manner," said UnCheol Lee, from the University of Michigan.
The researchers recorded electrical activity in the brains of 10 female participants with fibromyalgia. Baseline EEG results showed hypersensitive and unstable brain networks, Harris said.
Importantly, there was a strong correlation between the degree of ES conditions and the self-reported intensity of chronic pain reported by the patients at the time of EEG testing.
They used computer models of brain activity to compare stimulus responses of fibromyalgia patients to the normal condition.
As expected, the fibromyalgia model was more sensitive to electrical stimulation than the model without ES characteristics, Harris said.
Since ES can be modeled essentially outside of the brain or in a computer, researchers can exhaustively test for influential regions that transform a hypersensitive network into a more stable one.
These regions could then be targeted in living humans using noninvasive brain modulation therapies.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
